Evidence map›Paper›PMID 34594554›Full record

ArticleClinical case reports2021

Successful treatment of COVID-19-related acute respiratory distress syndrome with a rare blood type: A case report.

Hiroyuki Yamada, Shigeru Ohtsuru, Mika Nagatomo, Yohei Korogi, Ken Shinozuka, Naoya Tanabe, Shinichi Kai, Takeshi Matsubara, Isao Ito, Masahiro Ihara and 4 more

Abstract readCase Reports
In one paragraph

Article in Clinical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hiroyuki YamadaDepartment of Primary Care and Emergency Medicine Graduate School of Medicine Kyoto University Kyoto Japan.ORCID https://orcid.org/0000-0002-5167-3147
Shigeru OhtsuruDepartment of Primary Care and Emergency Medicine Graduate School of Medicine Kyoto University Kyoto Japan.
Mika NagatomoDepartment of Primary Care and Emergency Medicine Graduate School of Medicine Kyoto University Kyoto Japan.
Yohei KorogiDepartment of Reparatory Medicine Graduate School of Medicine Kyoto University Kyoto Japan.
Ken ShinozukaDepartment of Primary Care and Emergency Medicine Graduate School of Medicine Kyoto University Kyoto Japan.
Naoya TanabeDepartment of Reparatory Medicine Graduate School of Medicine Kyoto University Kyoto Japan.
Shinichi KaiDepartment of Anesthesia Graduate School of Medicine Kyoto University Kyoto Japan.
Takeshi MatsubaraDepartment of Nephrology Graduate School of Medicine Kyoto University Kyoto Japan.
Isao ItoDepartment of Reparatory Medicine Graduate School of Medicine Kyoto University Kyoto Japan.
Masahiro IharaDepartment of Medical Informatics Graduate School of Medicine Kyoto University Kyoto Japan.
Tomoharu TanakaDepartment of Anesthesia Graduate School of Medicine Kyoto University Kyoto Japan.
Genta KatoSolutions Center for Health Insurance Claims Kyoto University Hospital Kyoto Japan.
Miki NagaoDepartment of Clinical Laboratory Medicine Graduate School of Medicine Kyoto University Kyoto Japan.
Hiroshi DateDepartment of Thoracic Surgery Graduate School of Medicine Kyoto University Kyoto Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracorporeal membrane oxygenation is indispensable for critically severe COVID-19 patients. However, it would be inapplicable to patients with a rare blood type or blood transfusion refusal. In that case, severely conservative fluid management with the sacrifice of renal functions and hydrocortisone therapy should be considered for better oxygenation.

Indexed as

AKIARDSCOVID‐19ECMOhydrocortisonerhesus

Identifiers

PMID34594554
PMCPMC8462363

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.